IN SB0318 | 2023 | Regular Session
Status
Spectrum: Moderate Partisan Bill (Republican 5-1)
Status: Engrossed on March 1 2023 - 50% progression, died in committee
Action: 2023-03-06 - First reading: referred to Committee on Public Health
Pending: House Public Health Committee
Text: Latest bill text (Amended) [PDF]
Status: Engrossed on March 1 2023 - 50% progression, died in committee
Action: 2023-03-06 - First reading: referred to Committee on Public Health
Pending: House Public Health Committee
Text: Latest bill text (Amended) [PDF]
Summary
Audit of Medicaid program prescription drug costs. Provides that the office of the attorney general, or an independent auditor with experience auditing expenses related to prescription drugs that is hired through a request for proposal process by the attorney general, shall conduct an audit concerning prescription drug costs for the Medicaid program. Requires the auditor to examine cost sharing, spread pricing, patient steering, proper brand and generic definitions, effective rate clawbacks, medical loss ratio inflation, formulary compliance, discriminatory pricing, and any other metric determined by the attorney general. Provides that the audit look back period for the initial audit must be the previous five state fiscal years. Provides that the audit look back period for every audit conducted thereafter must be the previous three state fiscal years. Provides that the results of an audit must be provided to the legislative council.
Title
Audit of Medicaid program prescription drug costs.
Sponsors
Sen. Andy Zay [R] | Sen. Ed Charbonneau [R] | Sen. Lonnie Randolph [D] | Rep. Matthew Lehman [R] |
Rep. Ann Vermilion [R] | Rep. Martin Carbaugh [R] |
Roll Calls
2023-02-28 - Senate - Senate - Third reading (Y: 49 N: 0 NV: 0 Abs: 1) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-03-06 | House | First reading: referred to Committee on Public Health |
2023-03-01 | Senate | Referred to the House |
2023-02-28 | Senate | Cosponsors: Representatives Vermilion A and Carbaugh |
2023-02-28 | Senate | House sponsor: Representative Lehman |
2023-02-28 | Senate | Third reading: passed; Roll Call 193: yeas 49, nays 0 |
2023-02-27 | Senate | Second reading: ordered engrossed |
2023-02-23 | Senate | Senator Charbonneau added as second author |
2023-02-23 | Senate | Committee report: amend do pass, adopted |
2023-02-16 | Senate | Senator Randolph added as coauthor |
2023-02-16 | Senate | Committee report: amend do pass adopted; reassigned to Committee on Appropriations |
2023-01-12 | Senate | First reading: referred to Committee on Insurance and Financial Institutions |
2023-01-12 | Senate | Authored by Senator Zay |
Subjects
AUDITS AND AUDITORS
HEALTH, Health Care Costs; Health Insurance
LEGISLATIVE COUNCIL; LEGISLATIVE SERVICES AGENCY
HEALTH, Health Care Costs; Health Insurance
LEGISLATIVE COUNCIL; LEGISLATIVE SERVICES AGENCY